Report #2872779

Received Nov 14, 2025

Life-threateningER / ED visitOffice visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 62 yrs
State: UT
Recovered: Recovered
Vaccinated: Oct 16, 2025
Onset: Oct 19, 2025
Days to onset: 3
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (MODERNA MNEXSPIKE))	MODERNA	7+	3052864	IM / LA

Symptoms (16)

Abdominal painActivated protein C resistance testAntiphospholipid antibodiesComputerised tomogram abdomen abnormalCulture urineElectrocardiogramFull blood countGene mutation identification testInternational normalised ratioMesenteric vein thrombosisMetabolic function testProtein CProtein SProthrombin timeScan with contrastUrine analysis

Symptom narrative

Patient began having symptoms of abdominal pain around 3-4 days post vaccine date. Patient presented to the Urgent care on October 30th 2025 about 11 days after onset of symptoms which were nonspecific abdominal pain that was diffuse but mostly in the epigastric and RUQ. A CT scan was performed which revealed a superior mesenteric vein thrombosis. Patient was treated with lovenox in the ED and prescribed Eliquis and Celebrex to manage the thrombosis and associated pain. Hospitalization was considered but ultimately she was discharged from the ED.

Medical history

Dyslipidemia, Asthma

Other medications

Qvar, Zetia

Allergies

NKDA

Lab data

10/30/25: CT abdomen/pelvis with contrast, CMP, CBC, PT/INR, urinalysis and urine culture, EKG. On 11/14/25: factor V Leiden, activated protein C resistance, prothrombin G20210A, protein C, Protein S, antithrombin, and antiphospholipid, Jak 2 mutation.